Ex parte FRIEDMAN et al. - Page 7




          Appeal No. 95-4914                                                          
          Application No. 08/036,116                                                  


          on appeal, appellants argue that de Vringer is distinguished                
          from the appealed claims on the basis of the "oily liquid"                  
          component requirement as contrasted to de Vringer who teaches               
          the use of solid lipid particles.  Appellants provide no                    
          limiting definition in their specification requiring the                    
          claimed oily liquid component to be a liquid at any particular              
          temperature, however, while de Vringer indicates that his                   
          "solid lipoid nanoparticles" are "solid at room temperature".               
          See de Vringer at page 3, lines 40.  The examiner points out                
          that, like appellants’ claimed oily liquid component, which                 
          may be a "medium chain triglyceride oil" having "a chain                    
          length of 8 to 12 carbons" (appealed claim 3), de Vringer also              
          discloses triglycerides having 10-30 carbon atoms, such as                  
          glyceryl trilaurate (a 12 carbon chain length triglyceride) as              
          well as hydrogenated castor oil" as "solid lipid" materials                 
          useful in his compositions.  See de Vringer at page 3, lines                
          54-55.  Thus the record supports the examiner’s contention                  
          that some claimed "overlap" exists between the appellants’                  
          oily liquid component and the "solid lipoids" of de Vringer.                
          Moreover, de Vringer also contemplates the addition of "liquid              
          or semisolid lipids" which are mixed with the solid lipoid                  
                                          7                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007